Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BUPRENORPHINE HYDROCHLORIDE
- Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic
- Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
- Liposomal Bupivacaine vs Perineural Adjuvants in Adductor Canalf and iPACK Blocks in Total Knee Arthroplasty
- Comparative Analysis of Intraoperative Effect Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Spinal Anaesthesia in Lower Limb Orthopedic Surgeries to Evaluate the Hemodynamic Stability and Onset and Duration of Motor Block o
- Clinical Comparative Study Aiming to Evaluate Postoperative Effect of Using Intrathecal Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Lower Limb Vascular Surgeries on Pain Intensity, Analgesic Requirement and Shivering. Pat
- Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
- Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
- Adjunctive Cannabidiol for Recovery From Opioid Study
- Injectable Buprenorphine in Prison: a Preference Trial
- Wellcome Leap Psilocybin for OUD
- Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine
- An Exploratory Clinical Study of a Low-dose Buprenorphine Patch for the Treatment of Autism Spectrum Disorders
- Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulder Arthroscopy
- A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
- Semaglutide for Helping Opioid Recovery
- A Study to Test Whether BI 1356225 Improves Impulsive Behavior in Men With Opioid Use Disorder Who Are Taking Buprenorphine
- Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
- Better Options for Chronic Cancer Pain
- GLP-1R Agonist Treatment for Opioid Use Disorder
- Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
- Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder
- Standard Versus High Dose ED-Initiated Buprenorphine Induction
- ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
- Extended-release Buprenorphine as a Novel Low-dose Induction Strategy
- Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).
- Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
- Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use
- Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
- Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
- Buprenorphine for Individuals in Jail
- Cannabidiol in the Treatment of Opioid Use Disorder
- Psychopharmacological Treatment of Emotional Distress
- Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
- Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
- Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Assessing Optimal XRB Initiation Points in Jail
- Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
- Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
- Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
- Low-dose Versus a High-dose Sublingual Buprenorphine Induction
- Buprenorphine for Cancer Pain
- Transdermal Buprenorphine Patch for Laparoscopic Cholecystectomy
- Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery
- Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
- Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- Sublingual Dexmedetomidine for Treating Opioid Withdrawal
- Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations
- Novel Induction to Buprenorphine/Naloxone
- Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder
- Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder
- High Dose BUP Induction in the Emergency Department (ED)
- KetaMoHydBup: Pharmacokinetic Interaction of S-ketamine, Morphine, Hydromorphone and Buprenorphine
- Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
- Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery
- Suvorexant for Opioid/Stimulant Co-use
- Evaluating Buspirone to Treat Opioid Withdrawal
- Assessing Optimal XR-Buprenorphine Initiation Points in Jail
- Low-dose Buprenorphine Initiation of Opioid Use Disorder
- Anti-suicidal Effects of Buprenorphine In Depressed Individuals
- True Functional Restoration and Analgesia in Non-Radicular Low Back Pain
- Medication-assisted Treatment for Injecting Drug Users in Vietnam
- Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing TURP
- Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.
- Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual
- Monthly Injectable BUP for MA Use Disorder (MURB) Trial
- Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
- Clinical Response to Magnesium Sulfate as an Adjunct in the Anesthesia
- Postpartum MDMA Co-occurring PTSD and OUD
- Olanzapine in OUD Patients
- Extended-release Pharmacotherapy for Opioid Use Disorder
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
- Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
- Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP
- Are Adductor Canal Blocks With Bupivacaine and Added Magnesium Better at Managing Post-operative Pain Than Bupivacaine and Added Buprenorphine in Patients Undergoing Same-day Discharge Total Knee Arthroplasty?
- Serratus Anterior Plane Block With and Without Adjuvants in Video-assisted Thoracoscopy
- Pericapsular Nerve Group Block for Positional Pain and Postoperative Analgesia in Hip Fractures
- Safety of Cannabidiol Given to Subject With Methadone or Buprenorphine
- Cariprazine for Comorbid Cocaine and Opioid Use Didorder
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
- Role of Preoperative Transdermal Buprenorphine Patch in Reducing Postoperative Opioids Consumption in Patients Undergoing Total Knee Arthroplasties - A Randomised Controlled Trial.
- Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
- Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
- Are Superficial Parasternal Intercostal Plane (SPIP) Blocks With Bupivacaine and With or Without Adjuvants Helpful for Post-operative Pain After Coronary Artery Bypass Grafting?
- Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
- Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine
- Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder
- The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
- Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
- Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
- Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
- Buprenorphine Induction for Fentanyl Dependent Opioid Users
- Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients
- Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
- Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder
- Cannabidiol in Opioid Use Disorder and Chronic Pain
- HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
- Virginia Opioid Treatment-Emergency Department
- Providing Suboxone and PrEP Using Telemedicine
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- The Effect of Chronic Pain on Delay Discounting in Methadone Patients
- Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
- Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population
- Clinical Trials of Multivalent Opioid Vaccine Components
- Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)
- Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder
- A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
- Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
- Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
- EXHIT ENTRE Comparative Effectiveness Trial
- Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD
- Buprenorphine Loading in the Emergency Department
- Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
- Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion
- Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers
- Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
- Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
- Overlapping Buprenorphine Initiation (in Opioid Physical Dependence)
- Emergency Department-Initiated Buprenorphine Validation Network Trial
- Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
- Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
- Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women
- Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
- Ketamine for the Treatment of Opioid Use Disorder and Depression
- Adjunctive Effects of Psilocybin and Buprenorphine
- Medication Maintenance Therapy in Community Pharmacy Settings
- Single Ascending Dose Study of ALA-1000
- Opiate Suicide Study in Patients With Major Depression
- A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
- SUBLOCADE Rapid Initiation Extension Study
- Oxytocin, Stress, Craving, Opioid Use Disorder
- Effects of Dronabinol in Opioid Maintained Patients
- SUBLOCADE Rapid Initiation Study
- Buprenorphine Transdermal Patches Pharmacokinetic Study
- A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
- Acute Pain Management in Patients on Opioid Replacement Therapy
- Medication Treatment for Opioid Use Disorder in Expectant Mothers
- Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
- Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
- Rapid Initiation of Drug Treatment Engagement
- An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
- Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy
- Community Studies of Long Acting Buprenorphine (CoLAB)
- Medical Management of Sleep Disturbance During Opioid Tapering
- Cannabidiol as Adjunctive Treatment for Opioid Use Disorder
- Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch
- Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
- Medication Maintenance Therapy in Community Pharmacy Settings
- Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
- Buprenorphine-Fentanyl Interaction Study
- Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
- Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
- Impact of Lofexidine on Stress, Craving and Opioid Use
- Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
- Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
- Comparison of Three Opioid Detoxification Treatment Regimens
- Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
- Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
- Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
- Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
- Optimal Treatment of Veterans With PTSD and Comorbid OUD
- XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
- Improving Office Based Treatment of Opioid Use Disorder With Technology
- HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
- CBT4CBT for Office Based Buprenorphine
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
- Galantamine and CBT4CBT Pilot
- Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
- Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
- Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation
- Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair
- Facilitating Rapid Naltrexone Initiation
- Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient
- Maternal Buprenorphine-naloxone Treatment and the Infant
- Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
- Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
- Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
- Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain
- Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
- A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
- A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
- Brain Dopaminergic Signaling in Opioid Use Disorders
- Buprenorphine in the Emergency Department
- High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid
- Onsite Buprenorphine Treatment at Syringe Exchange Programs
- Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block
- Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
- Opioid Dependence Treatment Therapies in Pregnancy
- Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
- Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia
- Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
- A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
- Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
- Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
- Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty
- Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
- Open-Label Treatment Extension Study
- Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
- Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
- Single-dose, Study of RBP-6000 in Opioid Dependent Individuals
- Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper
- Phase II Pharmacokinetics Study of CAM2038
- Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
- Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
- Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
- A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
- A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
- Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology
- Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
- Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
- A Multiple Dose Opioid Challenge Study
- Medication-Assisted Treatment for Youth With Substance Use Disorders
- Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
- Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty
- Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
- Improving Treatment Outcomes for Prescription Opioid Dependence
- Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
- An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
- Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
- Buprenorphine Group Medical Visits in Primary Care
- Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
- The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects
- Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
- Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder
- Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
- Ropivacaine With Clonidine For Pediatric Rectus Sheath Blocks- The Magic Combination
- An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
- Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery
- A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
- Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
- Open-Label, Safety Study of Lofexidine
- The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
- Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access
- Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
- Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
- Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
- Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain
- Bioequivalence and Adhesion Comparison of Buprenorphine Patches
- Efficacy of Pain Treatment on Depression in Patients With Dementia
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
- Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
- The Effects of Hydromorphone on Responses to Verbal Tasks
- Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)
- Buprenorphine Treatment for Opioid Dependence
- Buprenorphine Used With Treatment Resistant Depression in Older Adults
- A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
- Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars
- A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
- Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
- Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone
- Drug Interaction & Methadone & Buprenorphine
- Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
- Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
- Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
- The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers
- Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)
- Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
- Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
- Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
- Buprenorphine to Improve HIV Care Engagement and Outcomes
- An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine
- Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults
- Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
- Improving Buprenorphine Detoxification Outcomes With Isradipine
- Nalrexone Facilitated Discontinuation of Buprenorphine
- Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
- Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film
- Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
- The Effects of Buprenorphine on Responses to Verbal Tasks
- Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine
- Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
- Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
- Dane County Drug Court Study for Addicted Offenders
- Extended Release Naltrexone for Opioid-Dependent Youth
- Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
- Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
- An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
- RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic La
- Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal
- Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
- Long-term Open-Label Safety Study to Evaluate EN3409
- Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
- Neurocognitive Effects of Opiate Agonist Treatment
- Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
- Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
- Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects
- Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
- Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
- Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
- Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines
- An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
- Buprenorphine Disposition and Cyclosporine
- Norspan Transdermal Patches Study in Osteoarthritis Patients
- Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
- Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
- Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects
- Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution
- Transfer of Subjects From Subutex/Suboxone to RBP-6300
- Buprenorphine Disposition and CYP3A
- Fetal and Infant Effects of Maternal Buprenorphine Treatment
- Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine
- Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution
- Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
- The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
- HIV, Buprenorphine, and the Criminal Justice System
- Buprenorphine in Acute Renal Colic Pain Management
- Pioglitazone to Treat Opioid Withdrawal Symptoms
- Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects
- Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome
- Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain
- Buprenorphine for Treatment Resistant Depression
- Cocaine Use Reduction With Buprenorphine
- A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)
- ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
- Improved Strategies for Outpatient Opioid Detoxification
- Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine
- ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
- Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
- Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain
- Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
- Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
- Efficacy of Buprenorphine for Treatment of Acute Pain
- Analgesic and Antihyperalgesic Effects of Morphine and Buprenorphine
- Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine
- Norspan Efficacy and Safety Among Elderly Subjects
- Drug-Drug Interaction Study Between Telaprevir and Buprenorphine
- Re-Treatment Study of Probuphine in Opioid Addiction
- Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals
- Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone
- Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole
- Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
- Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain
- Medications Development for Drug Abuse Disorders
- Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
- Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study
- The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers
- Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase
- HIV Risk Reduction in Subutex Injectors in Tbilisi
- Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy
- A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
- Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)
- Buprenorphine for Late-Life Treatment Resistant Depression
- Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
- Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
- Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy
- Dexamethasone Improves Postoperative Symptoms After Laparoscopic Cholecystectomy
- A Study Comparing Norspan Patch and Oral Tramadol
- Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
- Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
- Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
- Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur
- Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")
- Effects of Buprenorphine on Ulnar Nerve Motor Block
- A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain
- Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain
- Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
- Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
- Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
- Disulfiram for Cocaine Abuse in Buprenorphine Treatment
- Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
- Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.
- A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
- Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
- Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy
- A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality
- Buprenorphine/Raltegravir Pharmacokinetic Interaction Study
- TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.
- Study of Probuphine in Patients With Opioid Dependence
- A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
- Relapse Prevention to Reduce HIV Among Women Prisoners
- Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches
- Buprenorphine Naltrexone-P1 A-Cocaine
- Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers
- Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)
- Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)
- Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
- Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
- Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
- Effective Treatment for Prescription Opioid Abuse
- Abuse Liability of Suboxone Versus Subutex
- Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial
- Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
- Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
- Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices
- Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
- Safety and Tolerability of Buprenorphine/Naloxone Film Strips
- Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
- Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
- Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
- Sublingual Buprenorphine for Chronic Pain
- A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
- Buprenorphine for Prisoners
- Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
- Buprenorphine as a Treatment in Opiate Dependent Pain Patients
- Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee
- Buprenorphine for the Treatment of Neonatal Abstinence Syndrome
- The Discriminative Effects of Tramadol in Humans
- Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
- Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
- SSRI and Buprenorphine
- Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
- Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)
- Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)
- Buprenorphine's Dose Response Curve
- Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
- Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine
- Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement
- HIV Risk Reduction and Drug Abuse Treatment in Iran
- Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
- Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
- HIV Risk Reduction and Drug Abuse Treatment in Malaysia
- Treatment of Polydrug-Using Opiate Dependents During Withdrawal
- Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
- Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain
- Opioid Maintenance Medications Comparison Study
- Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
- Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
- Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
- Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
- The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.
- Starting Treatment With Agonist Replacement Therapies (START)
- Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
- Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
- Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain
- Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain
- A Stepwise Strategy Utilizing Buprenorphine and Methadone
- Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
- Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)
- RCT Comparing Methadone and Buprenorphine in Pregnant Women
- Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
- Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
- Lofexidine for Inpatient Opiate Detox
- The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration
- Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
- Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
- Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
- Science-Based Treatment for Opioid-Dependent Adolescents
- Neuraxial Pethidine After Lumbar Surgery Trial
- Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
- Abuse Potential of Buprenorphine/Naloxone
- Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
- Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
- Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
- Buprenorphine and Integrated HIV Care Evaluation
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
- Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
- Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
- Buprenorphine and Naloxone Combination Study - 10
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
- Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
- Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
- Buprenorphine Maintenance for Opiate Dependence - 6
- Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
- Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
- Evaluation of Liquid vs. Tablet Buprenorphine - 6
- Comparison of Buprenorphine and Methadone - 3
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
- Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
- Combining Behavioral Treatment With Agonist Maintenance - 1
- Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
- Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
- Buprenorphine Combination Tablet Feasibility - 1
- A Laboratory Model for Heroin Abuse Medications - 8
- Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
- Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
- Buprenorphine Pharmacology Related to Addiction Treatment - 21
- Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
- Buprenorphine Detoxification - BBDVI - 19
- Buprenorphine Pharmacology Related to Addiction Treatment - 18
- Alternate Day Buprenorphine Administration, Phase XII - 17
- Alternate Day Buprenorphine Administration, Phase XI - 16
- Alternate Day Buprenorphine Administration, Phase X - 15
- Alternate Day Buprenorphine Administration, Phase IX - 14
- Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
- Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
- Buprenorphine Detox With Two Types of Treatment. BBD II - 11
- Buprenorphine Detox With Two Types of Treatment. BBD I - 10
- Alternate-Day Buprenorphine Administration. Phase VIII - 9
- Alternate-Day Buprenorphine Administration. Phase VII - 8
- Alternate-Day Buprenorphine Administration. Phase VI - 7
- Alternate-Day Buprenorphine. Phase V - 6
- Alternate-Day Buprenorphine Administration. Phase IV - 5
- Alternate-Day Buprenorphine Administration. Phase II - 4
- Alternate-Day Buprenorphine Administration. Phase I - 3
- Gradual Vs. Rapid Buprenorphine Detoxification - 2
- Buprenorphine Dose Alteration Study - 1
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
- IV Cocaine Abuse: A Laboratory Model - 3
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
- Buprenorphine Dosing Interval - 5
- Methadone/Buprenorphine Cross-Over Study - 4
- Multicenter Clinical Trial of Buprenorphine - 3
- Clinical Rescue Protocol - 2
- Buprenorphine Maintenance Protocol - 1
- Buprenorphine Maintenance for Opioid Addicts - 3
- Buprenorphine Maintenance for Opioid Addicts - 2
- Buprenorphine Maintenance for Opioid Addicts - 1
- Cocaine Effects in Humans: Physiology and Behavior - 1
Clinical trials list
click for details